Searching you nailed it. Doctors who treat patient
Post# of 148110
It's interesting that HCQ SHOWS SIMILAR EFFICACY TO REMDESIVIR IN VITRO, HAS 60 YEARS OF SAFETY DATA, IS FDA APPROVED, IS ORALLY DOSED, AND COSTS $4. So why wasn't the controlled trial run for HCQ at the same time as Rem? Maybe it doesn't work but where is the quality data either way. What was the rationale for not running the trial at the same time? The feds have 29 mil doses donated from Novartis ready to deploy. Does this make sense to anyone?